Gelonghui On April 25, Baihua Pharmaceutical (600721.SH) announced its first quarter report for 2024. During the reporting period, it achieved operating income of 90.8764 million yuan, a year-on-year increase of 20.03%.
The net profit attributable to shareholders of the listed company was 20.6635 million yuan, a year-on-year increase of 209.02%.
The net profit after deducting non-recurring gains and losses attributable to shareholders of listed companies was 20.1866 million yuan, a year-on-year increase of 224.24%.
Basic earnings per share is 0.0541 yuan/share.